
LIXTW
USDLixte Biotechnology Holdings Inc. Warrants
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$0.025
고가
$0.030
저가
$0.025
거래량
0.01M
기업 기본 정보
산업
생명공학
국가
United States
거래 통계
평균 거래량
0.00M
거래소
NCM
통화
USD
52주 범위
관련 뉴스
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE's Ongoing Clinical Trials for Ovarian and Colorectal Cancers PASADENA, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- LIXTE
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
-Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian and Colorectal Cancer- -Received Exclusive Patent License Agreement with the NIH on
관련 주식

BGT
BlackRock Floating Rate Income Trust

JRI
Nuveen Real Asset Income and Growth Fund Common Shares of Beneficial Interest

SAFE
Safehold Inc. New

FCBC
First Community Bankshares Inc. (VA)

CGABL
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기